Home/Filings/4/0001758363-26-000002
4//SEC Filing

Turtle Cameron 4

Accession 0001758363-26-000002

CIK 0001636282other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 9:36 PM ET

Size

9.4 KB

Accession

0001758363-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
Turtle Cameron
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2026-01-02$30.47/sh12,709$387,243674,198 total
  • Sale

    Common Stock

    2026-01-02$31.79/sh2,191$69,652672,007 total
  • Sale

    Common Stock

    2026-01-02$32.39/sh100$3,239671,907 total
Footnotes (5)
  • [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  • [F2]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.20 to $31.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]Includes 159,713 shares of common stock that vest in monthly installments over approximately one year, subject to the continuing service of the Reporting Person on each vesting date.
  • [F4]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.29 to $32.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F5]The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.34 to $32.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Issuer

Spyre Therapeutics, Inc.

CIK 0001636282

Entity typeother

Related Parties

1
  • filerCIK 0001758363

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:36 PM ET
Size
9.4 KB